RRD International
- Categories: Biotechnology, Life Sciences, Pharmaceutical
- Client: RRD International
Website: http://www.rrdintl.com/
The Chase Group proudly announces the successful completion of a search for the Chief Development Officer/Chief Medical Officer position for RRD International. Dr. Ulrich Thienel will assume this leadership role within the company. Dr. Thienel will oversee the product development team as well as work with the President, CEO, and other members of the senior management team to create a business strategy that will maximize the ability of RRD to partner with pharmaceutical and biotechnology companies and investor groups.
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice…
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with…
A Successful Placement at Eisai, Inc.
The Chase Group is pleased to announce the successful completion of the Director, Clinical Research, Neuroscience at Eisai Inc. The successful candidate is a Board…
Another Successful Placement by The Chase Group at Marinus Pharmaceuticals
The Chase Group is pleased to announce the successful completion of the Executive Director, Head of Clinical Development Operations search at Marinus Pharmaceuticals. The successful…
Another Key Placement by The Chase Group
Dr. Eliel Bayever Joins OncoQuest as Chief Medical Officer. We are so proud to connect life-changing executives and companies!